CB

Christine Bartlett

Australian Clinical Labs Limited | Non-Executive Director
Ms. Bartlett is an experienced CEO and senior executive with line management experience gained through roles with IBM, Jones Lang LaSalle and National Australia Bank Limited. Her executive career included Australian, regional and global responsibilities based in Australia, the USA and Japan. She is currently a Non-Executive Director of Mirvac Group, Australian Clinical Labs Limited and TAL; and was previously a director of GBST Holdings Limited, Sigma Healthcare Limited, PropertyLook, National Nominees Ltd, the Australian Custodial Services Association, icare and The Smith Family. She is Chair of the Committee for Economic Development of Australia (CEDA). Other listed company directorships in the past 3 years: Australian Clinical Labs Limited (since August 2023); Mirvac Group (since December 2014); Sigma Healthcare Limited (March 2016 until December 2023). She is member of Health and Safety Committee and Sustainability Committee.

Companies and Roles

Company
Title
Tenure
Since
ACL
Australian Clinical Labs Limited
  • Non-Executive Director
2yrs, 10mthAug 2023
RWC
Reliance Worldwide Corporation Limited
  • Non-Executive Director
6yrs, 8mthNov 2019

Holdings

Company
Last Notice
Direct Shares
Indirect Shares
Options
Convertibles
30/06/25127,297N/AN/AN/A
RWC
Reliance Worldwide Corporation Limited
30/06/2530,00020,000N/AN/A
ACL
Australian Clinical Labs Limited
30/06/25N/A20,000N/AN/A
10/07/23230,08260,000N/AN/A

Transactions

Company
Date
Type
Amount
Price
Value
Notes
ACL
Australian Clinical Labs Limited
28/02/24
Buy
20,000$2.358$47,154On-market trade
10/07/23
Buy
6,506$0.812$5,286Directors' share plan
18/04/23
Buy
7,446$0.710$5,286Directors' share plan
14/02/23
Buy
22,125$2.260$50,002On-market trade
20/12/22
Buy
8,596$0.615$5,286Directors' share plan